ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells

BACKGROUND: The current standard of care for Glioblastoma Multiforme (GBM) consists of fractionated focal irradiation with concomitant temozolomide (TMZ) chemotherapy. A promising strategy to increase the efficacy of TMZ is through interference with the DNA damage repair machinery, by poly(ADP-ribos...

Descripción completa

Detalles Bibliográficos
Autores principales: Balvers, Rutger K, Lamfers, Martine LM, Kloezeman, Jenneke J, Kleijn, Anne, Berghauser Pont, Lotte ME, Dirven, Clemens MF, Leenstra, Sieger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359449/
https://www.ncbi.nlm.nih.gov/pubmed/25886061
http://dx.doi.org/10.1186/s12967-015-0427-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359449/
https://www.ncbi.nlm.nih.gov/pubmed/25886061
http://dx.doi.org/10.1186/s12967-015-0427-y

Ejemplares similares